Tags: Press release
Monument Chemical has acquired KMTEX LLC, a privately-owned specialty chemical distillations manufacturer based in Port Arthur, Texas.
July 23, 2021
Lonza, a CDMO partner to the biopharma industry, today announced the extension of its collaboration with a major biopharmaceutical partner for the commercial-scale manufacture of monoclonal antibodies, under a long-term agreement.
July 16, 2021
SOCMA on Thursday called on the Environmental Protection Agency (EPA) to uphold revisions made in 2019 to the Risk Management Plan (RMP) Rulemaking, which has the support of specialty and batch chemical manufacturers.
July 9, 2021
Lonza announced today the completion of the divestment of its former Specialty Ingredients business and operations to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.
July 2, 2021
SOCMA welcomes eight more companies to its growing specialty and fine chemical community – Milliken, Colonial Chemical, Oakwood Chemical, Ereztech, Entegris, Colour Synthesis Solutions, Berjé, Envirotech Services.
July 1, 2021
– Sun Chemical will increase prices across a broad portfolio of its packaging and commercial sheetfed inks, coatings, and adhesives in North America, effective July 1, 2021.
June 30, 2021
Colonial Chemical, Inc.
is a winner in the 2021 EPA Green Chemistry Challenge Awards Program, specifically in the focus area of The Design of Greener Chemicals. Colonial Chemical is being recognized for developing Suga®Boost surfactant blends that use more environmentally friendly chemicals than traditional cleaning surfactants.
June 21, 2021
The Society of Chemical Manufacturers & Affiliates (SOCMA) is pleased to announce the second annual 2021 Specialty Chemicals Industry Census+ will be available for download and key findings showcased during a virtual Executive Roundtable on Wednesday, June 23.
June 21, 2021
The Society of Chemical Manufacturers & Affiliates’ (SOCMA) today announced its centennial celebration and 2021 annual conference, SOCMA Week, to be held at the Royal Sonesta Hotel in New Orleans, LA, October 20-22.
June 9, 2021
Lonza today announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. The expanded collaboration will further extend the manufacture of the drug substance for the COVID-19 Vaccine Moderna and provides for the installation of a new manufacturing line for drug substance production at Lonza’s Geleen (NL) site.
June 2, 2021
